Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 17/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.46 |
| ▸ | HTR1F | P30939 | 1/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6331024 | 0.85 | HTR6 (0.52) | HTR6 | |
| SCHEMBL6335588 | 0.84 | HTR6 (0.60) | HTR6HDAC1HDAC2HDAC6HTR1A | |
| SCHEMBL6166554 | 0.82 | HTR6 (0.63) | HTR6HDAC1HDAC2HDAC6HTR1A | |
| SCHEMBL1171841 | 0.75 | HTR6 (1.00) | HTR6HDAC1HDAC2HDAC6HTR1A | |
| SCHEMBL3248158 | 0.73 | HTR6 (1.00) | HTR6HDAC1HDAC2HDAC6HTR1A | |
| SCHEMBL6404989 | 0.72 | HTR6 (0.54) | HTR6 | |
| SCHEMBL6336170 | 0.69 | PNMT (0.50) | HTR6 | |
| SCHEMBL6332940 | 0.68 | HTR6 (0.51) | HTR6HTR1ADRD2 | |
| SCHEMBL6328502 | 0.68 | HTR6 (0.40) | HTR6HTR1ADRD2 | |
| SCHEMBL949155 | 0.67 | HTR6 (0.65) | HTR6HDAC1HDAC2HDAC6HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6849644-B2 | Isoquinoline derivatives useful in the treatment of CNS disorders | SMITHKLINE BEECHAM P.L.C. (GB) | 2005-02-01 | — | — | US | claimed |